Steris Plc Quick Ratio (STE31) starting from the first quarter 2026 to first quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Steris Plc  (NYSE: STE31)

Steris Plc's Quick Ratio

STE31's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Steris Plc's Cash & cash equivalent grew by % in the Q1 2026 sequentially, faster than Current Liabilities, this led to improvement in Steris Plc's Quick Ratio to 0.38, Quick Ratio remained below Steris Plc average.

Within Medical Equipment & Supplies industry 195 other companies have achieved higher Quick Ratio than Steris Plc in first quarter 2026. While Quick Ratio total ranking in the first quarter 2026 has deteriorated compared to the prior quarter from to 3703.

Explain Quick Ratio?
How much Cash & cash equivalents STE31´s has?
What are STE31´s Current Liabilities?




STE31 Quick Ratio (Jun 30 2026)
Q1
(Dec 31 2022)
Q3
(Sep 30 2022)
Q2
(Jun 30 2022)
Q1
(Mar 31 2022)
Q4
Y / Y Current Liabilities Change 233.62 % 53.27 % 12.03 % -23.78 % 128.08 %
Y / Y Cash & cash equivalent Change - - -32.66 % -40.85 % -
Quick Ratio MRQ 0.38 - 0.31 0.36 -
STE31's Total Ranking # 3703 # # # #
Seq. Current Liabilities Change 44.88 % 5.59 % -3.89 % 126.89 % -33.44 %
Seq. Cash & cash equivalent Change - - -18.36 % - -



Quick Ratio first quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 196
Healthcare Sector # 1065
Overall Market # 3703


Quick Ratio Statistics
High Average Low
1.03 0.59 0.31
(Mar 31 2018)   (Sep 30 2022)




Financial Statements
Steris Plc's Current Liabilities $ 1,283 Millions Visit STE31's Balance sheet
Steris Plc's Cash & cash equivalent $ 482 Millions Visit STE31's Balance sheet
Source of STE31's Sales Visit STE31's Sales by Geography


Cumulative Steris Plc's Quick Ratio

STE31's Quick Ratio for the trailling 12 Months

STE31 Quick Ratio

(Jun 30 2026)
12 Months
(Dec 31 2022)
12 Months
(Sep 30 2022)
12 Months
(Jun 30 2022)
12 Months
(Mar 31 2022)
12 Months
Y / Y Current Liabilities TTM Growth 35.86 % 12.94 % 4.21 % 14.71 % 79.96 %
Y / Y Cash & cash equivalent TTM Growth -7.19 % -57.73 % -45.48 % -33.64 % 2.8 %
Quick Ratio TTM 0.27 0.19 0.3 0.36 0.4
Total Ranking TTM # 5104 # # # #
Seq. Current Liabilities TTM Growth 30.14 % 11.51 % 3.49 % -9.53 % 8.18 %
Seq. Cash & cash equivalent TTM Growth 83.94 % -27.74 % -13.61 % -19.18 % -16.22 %


On the trailing twelve months basis STE31 Cash & cash equivalent remained unchanged by % in Q1 2026 year on year, faster than Current Liabilities, this led to increase in in Steris Plc's Quick Ratio to 0.27, Quick Ratio remained below STE31 average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 264 other companies have achieved higher Quick Ratio than Steris Plc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2022 from to 5104.

Explain Quick Ratio?
How much Cash & cash equivalents STE31´s has?
What are STE31´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 265
Healthcare Sector # 1248
Within the Market # 5104


trailing twelve months Quick Ratio Statistics
High Average Low
0.63 0.45 0.16
(Dec 31 2020)   (Dec 31 2022)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Adagio Medical Holdings inc   1.02 $ 7.740  Millions$ 7.562  Millions
Plus Therapeutics Inc   1.00 $ 8.587  Millions$ 8.567  Millions
Pavmed Inc   1.00 $ 4.070  Millions$ 4.088  Millions
Sonoma Pharmaceuticals Inc   0.98 $ 5.338  Millions$ 5.447  Millions
Nuwellis Inc   0.98 $ 3.922  Millions$ 4.008  Millions
Electrocore Inc   0.97 $ 11.543  Millions$ 11.933  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  0.96 $ 10.924  Millions$ 11.366  Millions
Medline Inc   0.96 $ 2,677.000  Millions$ 2,803.000  Millions
Neuronetics Inc   0.88 $ 24.947  Millions$ 28.309  Millions
Orthopediatrics Corp  0.87 $ 45.879  Millions$ 52.852  Millions
Haemonetics Corporation  0.85 $ 223.384  Millions$ 263.235  Millions
Lifeward ltd   0.85 $ 9.448  Millions$ 11.159  Millions
Qhslab Inc   0.84 $ 0.317  Millions$ 0.376  Millions
Intelligent Bio Solutions Inc   0.84 $ 4.141  Millions$ 4.935  Millions
Integra Lifesciences Holdings Corp  0.83 $ 274.084  Millions$ 330.881  Millions
Lifestance Health Group Inc   0.82 $ 225.943  Millions$ 274.753  Millions
Pro dex Inc   0.81 $ 10.542  Millions$ 13.086  Millions
Carlisle Companies Incorporated  0.75 $ 665.300  Millions$ 888.400  Millions
Northview Acquisition Corp  0.73 $ 12.200  Millions$ 16.622  Millions
Livanova Plc  0.73 $ 516.619  Millions$ 707.004  Millions
Angiodynamics Inc   0.72 $ 53.864  Millions$ 74.717  Millions
Rosecliff Acquisition Corp I  0.70 $ 14.000  Millions$ 19.869  Millions
Innovage Holding Corp   0.69 $ 141.326  Millions$ 203.891  Millions
Msa Safety Inc  0.69 $ 200.057  Millions$ 288.899  Millions
Valion Bio Inc   0.69 $ 2.108  Millions$ 3.046  Millions
Lensar Inc   0.69 $ 13.565  Millions$ 19.640  Millions
West Pharmaceutical Services Inc   0.68 $ 435.800  Millions$ 640.500  Millions
Nexalin Technology Inc   0.68 $ 1.005  Millions$ 1.485  Millions
Orthofix Medical Inc   0.66 $ 103.810  Millions$ 157.010  Millions
Privia Health Group Inc   0.65 $ 412.200  Millions$ 634.444  Millions

Date modified: 2026-09-12T06:23:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.